Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters at once.
Researchers trained it on large public human and mouse genetics databases.
The tool helps pinpoint mutations linked to cancer, heart disease, and autoimmune disorders.
Scientists say it could accelerate drug discovery and future gene therapies.
Early users describe AlphaGenome as a major step forward in understanding the non-coding genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
